# A(f)MAZE-CABG Study

> **NCT00735722** · NA · TERMINATED · sponsor: **Abbott Medical Devices** · enrollment: 188 (actual)

## Conditions studied

- Coronary Arteriosclerosis
- Atrial Fibrillation
- Coronary Artery Bypass Graft Surgery

## Interventions

- **DEVICE:** HIFU AF Ablation

## Key facts

- **NCT ID:** NCT00735722
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 188 (ACTUAL)
- **Why stopped:** Insufficient recruitment
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735722, "A(f)MAZE-CABG Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00735722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*